Login Form Texas Department of State Health Services logo
Production


DO NOT ATTEMPT TO LOG ON UNLESS YOU ARE AN AUTHORIZED USER.


 
Portal Links
Main Content
  Hot Topics HT-1 HT-2 HT-3 HT-4 HT-5 HT-6 HT-7
Remdesivir Antiviral Medication Posted on 05/22/2020
Remdesivir is authorized under Food & Drug Administration (FDA) Emergency Use Authorization (EUA) for treatment of COVID-19. In accordance with Texas Health and Safety Code Sec. 161.00705, recording administration of Antiviral, Immunization and other Medication for disasters and emergencies must be entered in the Texas Immunization Registry, ImmTrac2.

Currently, Remdesivir can only be reported online in ImmTrac2. For additional information please visit our website at www.ImmunizeTexas.org.

Have specific ordering questions? Please contact the Vulnerable Populations and Facilities Task Force (VPFTF) at VPFTF@dshs.texas.gov.

Remdesivir Fact Sheet for Health Care Providers: www.fda.gov/media/137566/download

Remdesivir Fact Sheet for Patients and Parent/Caregivers: www.fda.gov/media/137565/download



ImmTrac2 Quick Guide - Change Password
Immunization Unit - Home Page
Vaccine Adverse Event Reporting System (VAERS)